Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-007640
Filing Date
2022-07-12
Accepted
2022-07-12 14:36:16
Documents
1
Period of Report
2022-07-01

Document Format Files

Seq Description Document Type Size
1 form4-07122022_110706.html 4  
1 form4-07122022_110706.xml 4 5869
  Complete submission text file 0001415889-22-007640.txt   7232
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EYENOVIA, INC 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017
Business Address
Palanki Ram (Reporting) CIK: 0001937411 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 221078988